Analystreport

Catalyst Biosciences Inc (NASDAQ: CBIO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Crescent Biopharma, Inc.  (CBIO) 
Last crescent biopharma, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors